Results 101 to 110 of about 32,832 (231)

Cardiovascular Challenges in Chronic Lymphocytic Leukemia (CLL) Patients Undergoing Bruton Tyrosine Kinase (BTK) Inhibitor Therapy

European Journal of Haematology, Volume 116, Issue 2, Page 104-115, February 2026.
ABSTRACT Background/Objectives Bruton tyrosine kinase inhibitors (BTKis) have revolutionized treatment for chronic lymphocytic leukemia (CLL), but cardiovascular (CV) toxicities pose significant challenges. Second‐generation BTKis offer improved target specificity, yet CV risks persist.
Stefano Oliva, Stefano Molica
wiley   +1 more source

Pulmonary Embolism (PE) to Chronic Thromboembolic Pulmonary Disease (CTEPD): Findings from a Survey of UK Physicians

Advances in Respiratory Medicine
Chronic thromboembolic pulmonary disease (CTEPD) is a complication of pulmonary embolism (PE). We conducted an online survey of UK PE-treating physicians to understand practices in the follow-up of PE and awareness of CTEPD.
Joanna Pepke-Zaba, Luke Howard, David G. Kiely, Shruti Sweeney, Martin Johnson   +4 more
doaj   +1 more source

Chronic Thromboembolic Pulmonary Hypertension: A Comprehensive Review and Multidisciplinary Approach to Surgical Treatment

, 2021
Qasim Al Abri, Alexander Lu, Mahesh Ramchandani   +2 more
openalex   +1 more source

Long‐term risk of cardiovascular events after COVID‐19 in the Swedish adult population—A matched cohort study

Journal of Internal Medicine, Volume 299, Issue 2, Page 241-254, February 2026.
Abstract Background The long‐term risk across severity strata of people infected with SARS‐CoV‐2 has not yet been comprehensively described. Methods Using nationwide registries, all COVID‐19 cases in Sweden with <2 vaccine doses, with and without initial hospitalization (February 1, 2020 to June 30, 2022), were identified and matched with non‐COVID ...
Martin Lindgren, Helen Sjöland, Demir Djekic, Josefina Robertson, Maria Åberg, Erik Thunström, Zacharias Mandalenakis, Jon Edqvist, Christina E. Lundberg, Martin Adiels, Annika Rosengren   +10 more
wiley   +1 more source

Contrast‐enhanced multidetector‐row computed tomography vs. Time‐resolved magnetic resonance angiography vs. contrast‐enhanced perfusion MRI: Assessment of treatment response by patients with inoperable chronic thromboembolic pulmonary hypertension [PDF]

, 2012
Yoshiharu Ohno, Hisanobu Koyama, Takeshi Yoshikawa, Mizuho Nishio, Sumiaki Matsumoto, Keiko Matsumoto, Nobukazu Aoyama, Munenobu Nogami, Kenya Murase, Kazuro Sugimura   +9 more
openalex   +1 more source

CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: HOW TO DIAGNOSE? A CASE REPORT

, 2023
Sidhi Laksono, Hillary Kusharsamita
openalex   +2 more sources

Ischemic Stroke in Hypereosinophilic Syndrome: A Clinicopathologic Study of Two Cases

Neuropathology, Volume 46, Issue 1, February 2026.
ABSTRACT Ischemic stroke is a rare complication of hypereosinophilic syndrome (HES). Manifestations of stroke in HES have been described in the radiologic literature; however the pathologic characterization of central nervous system (CNS) involvement in HES is limited.
Karina C. Martin, Dan Straathof, Chi Lai, Harry V. Vinters   +3 more
wiley   +1 more source

Pulmonary thrombo-endarterectomy for chronic thromboembolic pulmonary artery hypertension [PDF]

, 2021
Sofia Martìn Suàrez, Gregorio Gliozzi, Antonio Loforte, Fabio Niro, Mariafrancesca Fiorentino, Giulio Giovanni Cavalli, Massimiliano Palazzini, Francesco Saia, Niccolò Antonino Barbera, Marco La Monaca, Nazzareno Galiè, Davide Pacini   +11 more
openalex   +1 more source

Outcomes of Cerebral Venous Thrombosis in Patients With Myeloproliferative Neoplasms from a U.S. Nationwide Hospitalization Study

eJHaem, Volume 7, Issue 1, February 2026.
Nikhil Vojjala, Raj Shah, Viktoriya Gibatova, Lakshmi Kattamuri, Shubham Agrawal, Geetha Krishnamoorthy, Rushad Patell   +6 more
wiley   +1 more source

Effects of soluble guanylyl cyclase stimulation on muscle oxygenation and exercise capacity in heart failure with mildly reduced ejection fraction

Experimental Physiology, Volume 111, Issue 2, Page 474-488, 1 February 2026.
Abstract Heart failure (HF) with a mildly reduced ejection fraction (HFmrEF; 40%–49%) is present in ≤25% of HF patients. Therapeutic treatment options for HFmrEF‐associated exercise intolerance are limited. Nitric oxide (NO)‐independent stimulation of soluble guanylyl cyclase to improve peripheral vasodilatation offers a novel approach to enhance ...
Ramona E. Weber, Kiana M. Schulze, Andrew G. Horn, Tyler E. McCoach, Zachary J. White, K. Sue Hageman, Stephanie E. Hall, Peter Sandner, Brad J. Behnke, Timothy I. Musch, David C. Poole   +10 more
wiley   +1 more source